Department of Biomedical Engineering, Marquette University-Medical College of Wisconsin, Milwaukee, Wisconsin.
Clement J. Zablocki Department of Veterans Affairs Medical Center, Milwaukee, Wisconsin.
J Appl Physiol (1985). 2020 Apr 1;128(4):892-906. doi: 10.1152/japplphysiol.00789.2019. Epub 2020 Mar 5.
Mitochondrial membrane potential (Δψ) plays a key role in vital mitochondrial functions, and its dissipation is a hallmark of mitochondrial dysfunction. The objective of this study was to develop an experimental and computational approach for estimating Δψ in intact rat lungs using the lipophilic fluorescent cationic dye rhodamine 6G (R6G). Rat lungs were excised and connected to a ventilation-perfusion system. The experimental protocol consisted of three single-pass phases, loading, washing, and uncoupling, in which the lungs were perfused with R6G-containing perfusate, fresh R6G-free perfusate, or R6G-free perfusate containing the mitochondrial uncoupler FCCP, respectively. This protocol was carried out with lung perfusate containing verapamil vehicle or verapamil, an inhibitor of the multidrug efflux pump P-glycoprotein (Pgp). Results show that the addition of FCCP resulted in an increase in R6G venous effluent concentration and that this increase was larger in the presence of verapamil than in its absence. A physiologically based pharmacokinetic (PBPK) model for the pulmonary disposition of R6G was developed and used for quantitative interpretation of the kinetic data, including estimating Δψ. The estimated value of Δψ [-144 ± 24 (SD) mV] was not significantly altered by inhibiting Pgp with verapamil and is comparable with that estimated previously in cultured pulmonary endothelial cells. These results demonstrate the utility of the proposed approach for quantifying Δψ in intact functioning lungs. This approach has potential to provide quantitative assessment of the effect of injurious conditions on lung mitochondrial function and to evaluate the impact of therapies that target mitochondria. A novel experimental and computational approach for estimating mitochondrial membrane potential (Δψ) in intact functioning lungs is presented. The isolated rat lung inlet-outlet concentrations of the fluorescent cationic dye rhodamine 6G were measured and analyzed by using a computational model of its pulmonary disposition to determine Δψ. The approach has the potential to provide quantitative assessment of the effect of injurious conditions and their therapies on lung mitochondrial function.
线粒体膜电位(Δψ)在重要的线粒体功能中发挥着关键作用,其耗散是线粒体功能障碍的标志。本研究的目的是开发一种实验和计算方法,使用亲脂性荧光阳离子染料罗丹明 6G(R6G)来估计完整大鼠肺中的Δψ。将大鼠肺取出并连接到通气-灌注系统。实验方案包括三个单相阶段,即加载、洗涤和去耦,其中肺分别用含有 R6G 的灌流液、新鲜的不含 R6G 的灌流液或不含 R6G 的含有线粒体解偶联剂 FCCP 的灌流液进行灌注。该方案在含有维拉帕米载体或维拉帕米的肺灌流液中进行,维拉帕米是多药外排泵 P-糖蛋白(Pgp)的抑制剂。结果表明,FCCP 的加入导致 R6G 静脉流出浓度增加,并且在存在维拉帕米的情况下增加幅度大于不存在维拉帕米的情况。开发了一种用于 R6G 肺处置的基于生理的药代动力学(PBPK)模型,并用于对动力学数据进行定量解释,包括估计Δψ。使用维拉帕米抑制 Pgp 后估计的Δψ 值[-144 ± 24(SD)mV]没有显著改变,与先前在培养的肺内皮细胞中估计的值相当。这些结果表明,该方法可用于定量评估损伤条件对肺线粒体功能的影响,并评估针对线粒体的治疗方法的影响。提出了一种用于估计完整功能肺中线粒体膜电位(Δψ)的新的实验和计算方法。通过使用其肺部分布的计算模型来测量和分析荧光阳离子染料罗丹明 6G 的离体大鼠肺进出口浓度,以确定Δψ。该方法有可能提供对损伤条件及其对肺线粒体功能的治疗效果的定量评估。